These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 31196984)

  • 1. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism.
    Maini Rekdal V; Bess EN; Bisanz JE; Turnbaugh PJ; Balskus EP
    Science; 2019 Jun; 364(6445):. PubMed ID: 31196984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperine improves levodopa availability in the 6-OHDA-lesioned rat model of Parkinson's disease by suppressing gut bacterial tyrosine decarboxylase.
    Hu X; Yu L; Li Y; Li X; Zhao Y; Xiong L; Ai J; Chen Q; Wang X; Chen X; Ba Y; Wang Y; Wu X
    CNS Neurosci Ther; 2024 Feb; 30(2):e14383. PubMed ID: 37528534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitigating gut microbial degradation of levodopa and enhancing brain dopamine: Implications in Parkinson's disease.
    Cheng G; Hardy M; Hillard CJ; Feix JB; Kalyanaraman B
    Commun Biol; 2024 May; 7(1):668. PubMed ID: 38816577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease.
    van Kessel SP; Frye AK; El-Gendy AO; Castejon M; Keshavarzian A; van Dijk G; El Aidy S
    Nat Commun; 2019 Jan; 10(1):310. PubMed ID: 30659181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.
    Wang Y; Tong Q; Ma SR; Zhao ZX; Pan LB; Cong L; Han P; Peng R; Yu H; Lin Y; Gao TL; Shou JW; Li XY; Zhang XF; Zhang ZW; Fu J; Wen BY; Yu JB; Cao X; Jiang JD
    Signal Transduct Target Ther; 2021 Feb; 6(1):77. PubMed ID: 33623004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Gut Bacteria and Levodopa Metabolism.
    Xu K; Sheng S; Zhang F
    Curr Neuropharmacol; 2023; 21(7):1536-1547. PubMed ID: 36278467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut bacterial deamination of residual levodopa medication for Parkinson's disease.
    van Kessel SP; de Jong HR; Winkel SL; van Leeuwen SS; Nelemans SA; Permentier H; Keshavarzian A; El Aidy S
    BMC Biol; 2020 Oct; 18(1):137. PubMed ID: 33076930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the Enterococcus faecalis tyrosine decarboxylase operon involved in tyramine production.
    Connil N; Le Breton Y; Dousset X; Auffray Y; Rincé A; Prévost H
    Appl Environ Microbiol; 2002 Jul; 68(7):3537-44. PubMed ID: 12089039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tyrosine decarboxylation test does not differentiate Enterococcus faecalis from Enterococcus faecium.
    Marcobal A; de las Rivas B; García-Moruno E; Muñoz R
    Syst Appl Microbiol; 2004 Aug; 27(4):423-6. PubMed ID: 15368847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of volatile metabolites produced from levodopa metabolism by different bacteria strains of the gut microbiome.
    Pennington T; Eshima J; Smith BS
    BMC Microbiol; 2024 Jul; 24(1):260. PubMed ID: 38997651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of L-dopa and carbidopa combined treatments on human catecholaminergic cells.
    Colamartino M; Padua L; Meneghini C; Leone S; Cornetta T; Testa A; Cozzi R
    DNA Cell Biol; 2012 Nov; 31(11):1572-9. PubMed ID: 23020119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats.
    van Kessel SP; Bullock A; van Dijk G; El Aidy S
    mSystems; 2022 Feb; 7(1):e0119121. PubMed ID: 35076270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First evidence of a membrane-bound, tyramine and beta-phenylethylamine producing, tyrosine decarboxylase in Enterococcus faecalis: a two-dimensional electrophoresis proteomic study.
    Pessione E; Pessione A; Lamberti C; Coïsson DJ; Riedel K; Mazzoli R; Bonetta S; Eberl L; Giunta C
    Proteomics; 2009 May; 9(10):2695-710. PubMed ID: 19405032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A widely distributed metalloenzyme class enables gut microbial metabolism of host- and diet-derived catechols.
    Maini Rekdal V; Nol Bernadino P; Luescher MU; Kiamehr S; Le C; Bisanz JE; Turnbaugh PJ; Bess EN; Balskus EP
    Elife; 2020 Feb; 9():. PubMed ID: 32067637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of NaCl Treatments on Tyramine Biosynthesis of Enterococcus faecalis.
    Liu F; Wang X; Du L; Wang D; Zhu Y; Geng Z; Xu X; Xu W
    J Food Prot; 2015 May; 78(5):940-5. PubMed ID: 25951388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats.
    Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
    Eur J Pharmacol; 1998 Jul; 353(1):33-42. PubMed ID: 9721037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DopAmide: Novel, Water-Soluble, Slow-Release l-dihydroxyphenylalanine (l-DOPA) Precursor Moderates l-DOPA Conversion to Dopamine and Generates a Sustained Level of Dopamine at Dopaminergic Neurons.
    Atlas D
    CNS Neurosci Ther; 2016 Jun; 22(6):461-7. PubMed ID: 26861609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease.
    Kostrzewa RM; Kostrzewa JP; Brus R
    Amino Acids; 2002; 23(1-3):57-63. PubMed ID: 12373519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.